Skip to main content

Advertisement

SpringerLink
Log in

The Central Theme of Parkinson’s Disease: α-Synuclein

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, defined by the presence of resting tremor, muscular rigidity, bradykinesia, and postural instability. PD is characterized by the progressive loss of dopaminergic neurons within the substantia nigra pars compacta of the midbrain. The neuropathological hallmark of the disease is the presence of intracytoplasmic inclusions, called Lewy bodies (LBs) and Lewy neurites (LNs), containing α-synuclein, a small protein which is widely expressed in the brain. The α-synuclein gene, SNCA, is located on chromosome 4q22.1; SNCA-linked PD shows an autosomal dominant inheritance pattern with a relatively early onset age, and it usually progresses rapidly. Three missense mutations, A53T, A30P, and E46K, in addition to gene multiplications of the SNCA have been described so far. Although it is clear that LBs and LNs contain mainly the α-synuclein protein, the mechanism(s) which leads α-synuclein to accumulate needs to be elucidated. The primary question in the molecular pathology of PD is how wild-type α-synuclein aggregates in PD, and which interacting partner(s) plays role(s) in the aggregation process. It is known that dopamine synthesis is a stressfull event, and α-synuclein expression somehow affects the dopamine synthesis. The aberrant interactions of α-synuclein with the proteins in the dopamine synthesis pathway may cause disturbances in cellular mechanisms. The normal physiological folding state of α-synuclein is also important for the understanding of pathological aggregates. Recent studies on the α-synuclein protein and genome-wide association studies of the α-synuclein gene show that PD has a strong genetic component, and both familial and idiopathic PD have a common denominator, α-synuclein, at the molecular level. It is clear that the disease process in Parkinson’s disease, as in other neurodegenerative disorders, is very complicated; there can be several different molecular pathways which are responsible for diverse and possibly also unrelated functions inside the neuron, playing roles in PD pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bekris LM, Mata IF, Zabetian CP (2010) The genetics of parkinson disease. J Geriatr Psychiatry Neurol 23:228–242

    Article  PubMed  Google Scholar 

  2. Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE (2009) Neuropathology of non-motor features of parkinson disease. Parkinsonism Relat Disord 15(Suppl. 3):S1–S5

    Article  PubMed  Google Scholar 

  3. Gasser T (2010) Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects. Prog Brain Res 183:3–20

    PubMed  CAS  Google Scholar 

  4. Gasser T, Hardy J, Mizuno Y (2011) Milestones in PD genetics. Mov Disord 26(6):1042–1048

    Article  PubMed  Google Scholar 

  5. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840

    Article  PubMed  CAS  Google Scholar 

  6. Wolters E (2009) Non-motor extranigral signs and symptoms in Parkinson’s disease. Parkinsonism Relat Disord 15(Suppl. 3):S6–S12

    Article  PubMed  Google Scholar 

  7. Gasser T (2009) Molecular pathogenesis of Parkinson disease: ınsights from genetic studies. Expert Rev Mol Med 11:E22

    Article  PubMed  Google Scholar 

  8. Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson’s disease. Trends Neurosci 30:244–250

    Article  PubMed  CAS  Google Scholar 

  9. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene ıdentified in families with Parkinson’s disease. Science 276:2045–2047

    Article  PubMed  CAS  Google Scholar 

  10. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet 18:106–108

    Article  PubMed  Google Scholar 

  11. Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164–173

    Article  PubMed  CAS  Google Scholar 

  12. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destée A (2004) Alpha-synuclein locus duplication as a cause of familial parkinson’s disease. Lancet 364:1167–1169

    Article  PubMed  CAS  Google Scholar 

  13. Pirkevi C (2009) Parkinson’s disease in Turkish patients: molecular defects in familial and isolated cases. Boğaziçi University, Dissertation

    Google Scholar 

  14. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302:841

    Article  PubMed  CAS  Google Scholar 

  15. Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA (2001) Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol 49:313–319

    Article  PubMed  CAS  Google Scholar 

  16. Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson EM, Schlüle B, Langston JW, Middleton FA, Ross OA, Hulihan M, Gasser T, Farrer MJ (2007) Phenotypic variation in a large swedish pedigree due to SNCA duplication and triplication. Neurology 68(12):916–922

    Article  PubMed  CAS  Google Scholar 

  17. Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, Bonnet AM, Brefel-Courbon C, Heath S, Zelenika D, Agid Y, Dürr A, Brice A (2009) Alpha-synuclein gene rearrangements in dominantly ınherited parkinsonism: frequency, phenotype and mechanisms. Arch Neurol 66(1):102–108

    Article  PubMed  Google Scholar 

  18. Venda LL, Cragg SJ, Buchman VL, Wade-Martins R (2010) Alpha-synuclein and dopamine at the crossroads of Parkinson’s disease. Trends Neurosci 33:559–568

    Article  PubMed  CAS  Google Scholar 

  19. Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41(12):1308–12

    Article  PubMed  Google Scholar 

  20. Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, Hardy J, Farrer MJ, Cookson MR (2003) Coordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J Neurochem 85:957–968

    Article  PubMed  CAS  Google Scholar 

  21. Yu S, Zuo X, Li Y, Zhang C, Zhou M, Zhang YA, Uéda K, Chan P (2004) Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci Lett 367:34–39

    Article  PubMed  CAS  Google Scholar 

  22. Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Björklund A (2002) Parkinson-like neurodegeneration ınduced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 22:2780–2791

    PubMed  CAS  Google Scholar 

  23. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and ınclusion body formation in alpha-synuclein mice: ımplications for neurodegenerative disorders. Science 287:1265–1269

    Article  PubMed  CAS  Google Scholar 

  24. Peng X, Tehranian R, Dietrich P, Stefanis L, Perez RG (2005) Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci 118:3523–3530

    Article  PubMed  CAS  Google Scholar 

  25. Xu J, Kao SY, Lee FJS, Song W, Jin LW, Yankner BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nature Med. 8:600–606

    Article  PubMed  CAS  Google Scholar 

  26. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM-Y (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636–640

    Article  PubMed  CAS  Google Scholar 

  27. Lee JT, Wheeler TC, Li L, Chin L-S (2008) Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum Molec Genet 17:906–917

    Article  PubMed  CAS  Google Scholar 

  28. Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S (2004) Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and ıts presence in cellular ınclusions and Lewy bodies ımply a role in Parkinson's disease. Proc Nat Acad Sci 101:5500–5505

    Article  PubMed  CAS  Google Scholar 

  29. Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC (2010) Alpha-synuclein promotes SNARE-complex assembly ın vivo and ın vitro. Science 329:1663–1667

    Article  PubMed  CAS  Google Scholar 

  30. Bartels T, Choi JG, Selkoe DJ (2011) Alpha-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107–111

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We would like to thank Boğaziçi University Research Funds and TÜBİTAK (108T179) for their financial support. The invaluable contribution of Suna and İnan Kıraç Foundation to our research is especially acknowledged.

Author information

Authors and Affiliations

  1. Department of Molecular Biology and Genetics, Neurodegeneration Research Laboratory (NDAL), Boğaziçi University, Bebek, Istanbul, Turkey

    Mehmet Ozansoy & A. Nazli Başak

Authors
  1. Mehmet Ozansoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Nazli Başak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Nazli Başak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozansoy, M., Başak, A.N. The Central Theme of Parkinson’s Disease: α-Synuclein. Mol Neurobiol 47, 460–465 (2013). https://doi.org/10.1007/s12035-012-8369-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-012-8369-3

Keywords

Search

Navigation